99 related articles for article (PubMed ID: 29329996)
21. The influence of the bowel and bladder preparation protocol for radiotherapy of prostate cancer using kilo-voltage cone beam CT: Our experience.
Heng SP; Low SH; Sivamany K
Indian J Cancer; 2015; 52(4):639-44. PubMed ID: 26960504
[TBL] [Abstract][Full Text] [Related]
22. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer.
Teh BS; Dong L; McGary JE; Mai WY; Grant W; Butler EB
Med Dosim; 2005; 30(1):25-30. PubMed ID: 15749008
[TBL] [Abstract][Full Text] [Related]
23. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
Vargas C; Martinez A; Kestin LL; Yan D; Grills I; Brabbins DS; Lockman DM; Liang J; Gustafson GS; Chen PY; Vicini FA; Wong JW
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1297-308. PubMed ID: 16029785
[TBL] [Abstract][Full Text] [Related]
24. Impact of image guidance on outcomes after external beam radiotherapy for localized prostate cancer.
Kupelian PA; Willoughby TR; Reddy CA; Klein EA; Mahadevan A
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1146-50. PubMed ID: 17919834
[TBL] [Abstract][Full Text] [Related]
25. Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancer.
Mendenhall NP; Hoppe BS; Nichols RC; Mendenhall WM; Morris CG; Li Z; Su Z; Williams CR; Costa J; Henderson RH
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):596-602. PubMed ID: 24521677
[TBL] [Abstract][Full Text] [Related]
26. Multi-institutional Phase II study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicities.
Nihei K; Ogino T; Onozawa M; Murayama S; Fuji H; Murakami M; Hishikawa Y
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):390-6. PubMed ID: 20832180
[TBL] [Abstract][Full Text] [Related]
27. Image guided hypofractionated radiotherapy and quality of life for localized prostate cancer: prospective longitudinal study in 337 patients.
Jereczek-Fossa BA; Santoro L; Zerini D; Fodor C; Vischioni B; Dispinzieri M; Bossi-Zanetti I; Gherardi F; Bonora M; Caputo M; Vavassori A; Cambria R; Garibaldi C; Cattani F; Matei DV; Musi G; De Cobelli O; Orecchia R
J Urol; 2013 Jun; 189(6):2099-103. PubMed ID: 23313200
[TBL] [Abstract][Full Text] [Related]
28. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
[TBL] [Abstract][Full Text] [Related]
29. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
30. [New methods in the treatment of localized prostate cancer: use of dynamic arc therapy and kV cone-beam CT positioning].
Szappanos S; Farkas R; Lőcsei Z; László Z; Kalincsák J; Bellyei S; Sebestyén Z; Csapó L; Sebestyén K; Halász J; Musch Z; Beöthe T; Farkas L; Mangel L
Orv Hetil; 2014 Aug; 155(32):1265-72. PubMed ID: 25087218
[TBL] [Abstract][Full Text] [Related]
31. Post-prostatectomy image-guided radiation therapy: evaluation of toxicity and inter-fraction variation using online cone-beam CT.
Eldredge HB; Studenski M; Keith SW; Trabulsi E; Lallas CD; Gomella LG; Dicker AP; Showalter TN
J Med Imaging Radiat Oncol; 2011 Oct; 55(5):507-15. PubMed ID: 22008172
[TBL] [Abstract][Full Text] [Related]
32. A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer.
Bayley AJ; Catton CN; Haycocks T; Kelly V; Alasti H; Bristow R; Catton P; Crook J; Gospodarowicz MK; McLean M; Milosevic M; Warde P
Radiother Oncol; 2004 Jan; 70(1):37-44. PubMed ID: 15036850
[TBL] [Abstract][Full Text] [Related]
33. Hypofractionated IMRT of the prostate bed after radical prostatectomy: acute toxicity in the PRIAMOS-1 trial.
Katayama S; Striecker T; Kessel K; Sterzing F; Habl G; Edler L; Debus J; Herfarth K
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):926-33. PubMed ID: 25216858
[TBL] [Abstract][Full Text] [Related]
34. Prostate hypofractionated radiation therapy with injection of hyaluronic acid: acute toxicities in a phase 2 study.
Chapet O; Decullier E; Bin S; Faix A; Ruffion A; Jalade P; Fenoglietto P; Udrescu C; Enachescu C; Azria D
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):730-6. PubMed ID: 25752385
[TBL] [Abstract][Full Text] [Related]
35. Rectal dose variation during the course of image-guided radiation therapy of prostate cancer.
Chen L; Paskalev K; Xu X; Zhu J; Wang L; Price RA; Hu W; Feigenberg SJ; Horwitz EM; Pollack A; Ma CM
Radiother Oncol; 2010 May; 95(2):198-202. PubMed ID: 20303193
[TBL] [Abstract][Full Text] [Related]
36. Three-dimensional conformal arc radiotherapy using a C-arm linear accelerator with a computed tomography on-rail system for prostate cancer: clinical outcomes.
Kumabe A; Fukuhara N; Utsunomiya T; Kawase T; Iwata K; Okada Y; Sutani S; Ohashi T; Oya M; Shigematsu N
Radiat Oncol; 2015 Oct; 10():208. PubMed ID: 26458948
[TBL] [Abstract][Full Text] [Related]
37. Scanned ion beam therapy for prostate carcinoma: Comparison of single plan treatment and daily plan-adapted treatment.
Hild S; Graeff C; Rucinski A; Zink K; Habl G; Durante M; Herfarth K; Bert C
Strahlenther Onkol; 2016 Feb; 192(2):118-26. PubMed ID: 26614393
[TBL] [Abstract][Full Text] [Related]
38. Stereotactic body re-irradiation therapy for locally recurrent prostate cancer after external-beam radiation therapy: Initial report.
Janoray G; Reynaud-Bougnoux A; Ruffier-Loubière A; Bernadou G; Pointreau Y; Calais G
Cancer Radiother; 2016 Jun; 20(4):275-81. PubMed ID: 27342944
[TBL] [Abstract][Full Text] [Related]
39. Prostate bed motion may cause geographic miss in post-prostatectomy image-guided intensity-modulated radiotherapy.
Bell LJ; Cox J; Eade T; Rinks M; Kneebone A
J Med Imaging Radiat Oncol; 2013 Dec; 57(6):725-32. PubMed ID: 24283563
[TBL] [Abstract][Full Text] [Related]
40. Acute toxicity of image-guided hypofractionated radiotherapy for prostate cancer: nonrandomized comparison with conventional fractionation.
Jereczek-Fossa BA; Zerini D; Fodor C; Santoro L; Cambria R; Garibaldi C; Tagaste B; Vavassori A; Cattani F; Alterio D; Gherardi F; Serafini F; Rocco B; Musi G; De Cobelli O; Orecchia R
Urol Oncol; 2011; 29(5):523-32. PubMed ID: 20005749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]